SCOPUS 정보 검색 플랫폼

Volumn 22, Issue 2 B, 2002, Pages 1295-1300

Correlation of clinical outcome with p53 and p21 status in patients with advanced transitional-cell carcinoma treated with paclitaxel and carboplatin

(10) Flamm, Maria a Brodowicz, Thomas a Haitel, Andrea a Susani, Martin a Tomek, Sandra a Köstler, Wofgang a Pycha, Armin a Kratzik, Christian a Marberger, Michael a Zielinski, Christoph C a

a MEDICAL UNIVERSITY OF VIENNA (Austria)

Author keywords

Carboplatin; p21; p53; Paclitaxel; Transitional cell carcinoma

Indexed keywords

CARBOPLATIN; PACLITAXEL; PROTEIN P21; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UROGENITAL TRACT CANCER;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, TRANSITIONAL CELL; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PACLITAXEL; TUMOR SUPPRESSOR PROTEIN P53; UROLOGIC NEOPLASMS;

EID: 0036330663 PISSN: 02507005 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (5)

References (37)

1
- 0029586840
- p53 overexpression as a prognostic factor for advanced staged bladder cancer
- (1995) Eur J Cancer , vol.31 A , pp. 2243-2247
- Kuczyk, M.A.¹ Bokemeyer, C.² Serth, J.³ Hervatin, C.⁴ Oelke, M.⁵ Hofner, K.⁶ Tan, H.K.⁷ Jonas, U.⁸

2
- 0034622082
- Urothelial carcinoma associated with the use of a chinese herb (aristolochia fangchi)
- (2000) N Engl J Med , vol.342 , pp. 1686-1692
- Petein, M.¹ Deperieux, M.F.² De Pauw, L.³ Abramowicz, D.⁴ Vereerstraeten, P.⁵ Vanherwghem, J.L.⁶

3
- 0034622021
- Cancer and herbs
- (2000) N Engl J Med , vol.342 , pp. 1742-1743
- Kessler, D.A.¹

4
- 0023857065
- MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium
- (1988) J Urol , vol.139 , pp. 461-469
- Sternberg, C.N.¹ Yagoda, A.² Scher, H.I.³ Watson, R.C.⁴ Herr, H.W.⁵ Morse, M.J.⁶ Sogani, P.C.⁷ Vaughan D.E., Jr.⁸ Bander, N.⁹ Weiselberg, L.R.¹⁰

5
- 0026625220
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study
- (1992) J Clin Oncol , vol.10 , pp. 1066-1073
- Loehrer, P.J.¹ Einhorn, L.H.² Elson, P.J.³ Crawford, E.D.⁴ Kuebler, P.⁵ Tannock, I.⁶ Raghavan, D.⁷ Stuart-Harris, R.⁸ Sonosdy, M.F.⁹ Lowe, B.A.¹⁰

6
- 0025297496
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors
- (1990) J Clin Oncol , vol.8 , pp. 1050-1055
- Logothetis, C.J.¹ Dexeus, F.H.² Finn, L.³ Sella, A.⁴ Amato, R.J.⁵ Ayala, A.G.⁶ Kilbourn, R.G.⁷

7
- 0033857218
- Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study
- (2000) J Clin Oncol , vol.18 , pp. 3068-3077
- Von der Maase, H.¹ Hansen, S.W.² Roberts, J.T.³ Dogliotti, L.⁴ Oliver, T.⁵ Moore, M.J.⁶ Bodrogi, I.⁷ Albers, P.⁸ Knuth, A.⁹ Lippert, C.M.¹⁰ Kerbrat, P.¹¹ Sanchez Rovira, P.¹² Wersall, P.¹³ Cleall, S.P.¹⁴ Rochowdhury, D.F.¹⁵ Temlin, I.¹⁶ Visseren-Grul, C.M.¹⁷ Conte, P.F.¹⁸

8
- 0031962154
- Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: An active and tolerable outpatient regimen
- (1998) J Clin Oncol , vol.16 , pp. 255-260
- Vaughn, D.J.¹ Malkovicz, S.B.² Zoltick, B.³ Mick, R.⁴ Ramchandani, P.⁵ Holroyde, C.⁶ Armstead, B.⁷ Fox, K.⁸ Wein, A.⁹

9
- 0031844185
- Paclitaxel and carboplatin in patients with metastatic transitional-cell carcinoma: Results of a phase II trial
- (1998) Brit J Cancer , vol.78 , pp. 370-374
- Zielinski, C.C.¹ Schnack, B.² Grbovic, M.³ Brodowicz, T.⁴ Wiltschke, C.⁵ Steger, G.⁶ Pfluger, H.⁷ Marberger, M.⁸

10
- 0033105237
- Paclitaxel and carboplatin in patients with metastatic transitional cell carcinoma of the urinary tract
- (1999) Urology , vol.53 , pp. 510-515
- Pycha, A.¹ Grbovic, M.² Posch, B.³ Schnack, B.⁴ Haitel, A.⁵ Heinz-Peer, G.⁶ Zielinski, C.C.⁷ Marberger, M.⁸

11
- 0031803705
- Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma
- (1998) J Clin Oncol , vol.16 , pp. 1844-1848
- Redman, B.G.¹ Smith, D.C.² Flaherty, L.³ Du, W.⁴ Hussain, M.⁵

12
- 0342758712
- Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: The importance of survival as a clinical trial end point
- (2000) J Clin Oncol , vol.18 , pp. 2537-2544
- Small, E.J.¹ Lew, D.² Redman, B.G.³ Petrylak, D.P.⁴ Hammend, N.⁵ Gross, H.M.⁶ Eastham, J.A.⁷ Crawford, E.D.⁸

13
- 0032527133
- WAF1/CIP1 expression on tumor progression in bladder cancer
- (1998) J Natl Cancer Inst , vol.90 , pp. 1072-1079
- Stein, J.P.¹ Ginsberg, D.A.² Grossfeld, G.D.³ Chatterjee, S.J.⁴ Esrig, D.⁵ Dickinson, M.G.⁶ Groshen, S.⁷ Taylor, C.R.⁸ Jones, P.A.⁹ Skinner, P.J.¹⁰ Cote, R.J.¹¹

14
- 0030941458
- p53, the cellular gatekeeper for growth and division
- (1997) Cell , vol.88 , pp. 323-331
- Levine, A.J.¹

15
- 0029845760
- Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
- (1996) J Natl Cancer Inst , vol.88 , pp. 1442-1455
- Harris, C.C.¹

16
- 0034110698
- Molecular epidemiology and carcinogenesis: Endogenous and exogenous carcinogens
- (2000) Mutat Res , vol.462 , pp. 311-322
- Hussain, S.P.¹ Harris, C.C.²

17
- 0027944206
- p53 status and the efficacy of cancer therapy in vivo
- (1994) Science , vol.266 , pp. 807-810
- Lowe, S.W.¹ Bodis, S.² McClatchey, A.³ Remington, L.⁴ Ruley, H.E.⁵ Fisher, D.E.⁶ Housman, D.E.⁷ Jacks, T.⁸

18
- 0027451668
- p53 dependent apoptosis modulates the cytotoxicity of anti-cancer agents
- (1993) Cell , vol.74 , pp. 957-967
- Lowe, S.W.¹ Ruley, H.E.² Jacks, T.³ Housman, D.E.⁴

19
- 0027359827
- WAF1, a potentional mediator of p53 tumor suppression
- (1993) Cell , vol.75 , pp. 817-825
- El-Deiry, W.S.¹ Tokino, T.² Velculescu, V.E.³ Levy, D.B.⁴ Parsons, R.⁵ Trent, J.M.⁶ Lin, D.⁷ Mercer, W.E.⁸ Kinzler, K.W.⁹ Vogelstein, B.¹⁰

20
- 0028294605
- WAF1/CIP1 is induced in p53 mediated G1 arrest and apoptosis
- (1994) Cancer Res , vol.54 , pp. 1169-1174
- El-Deiry, W.S.¹ Harper, J.W.² O'Connor, P.M.³ Velculescu, V.E.⁴ Canman, C.E.⁵ Jackman, J.⁶ Peitenpol, J.A.⁷ Burrel, M.⁸ Hill, D.E.⁹ Wang, Y.¹⁰

21
- 0027717617
- P21 is a universal inhibitor of cyclin kinases
- (1993) Nature , vol.366 , pp. 701-704
- Xiong, Y.¹ Hannon, G.H.² Zhang, H.³ Casso, D.⁴ Kobayashi, R.⁵ Beach, D.⁶

22
- 0029922621
- p53 tumor suppressor gene: From the basic research laboratory to the clinic - An abridged historical perspective
- (1996) Carcinogenesis , vol.17 , pp. 1187-1198
- Harris, C.C.¹

23
- 0030026934
- Loss of normal p53 function confers to sensitization to Taxol by increasing G2/M arrest and apoptosis
- (1996) Nat Med , vol.2 , pp. 72-79
- Wahl, A.F.¹ Donaldson, K.L.² Fairchild, C.³ Lee, F.Y.⁴ Foster, S.A.⁵ Demers, G.W.⁶ Galloway, D.A.⁷

24
- 0031818322
- Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis
- (1998) Exp Cell Res , vol.241 , pp. 96-101
- Vikhanskaya, F.¹ Vignati, S.² Beccaglia, P.³ Ottoboni, C.⁴ Russo, P.⁵ D'Incalci, M.⁶ Broggini, M.⁷

25
- 0028875410
- Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
- (1995) Nat Med , vol.1 , pp. 1029-1034
- Bergh, J.¹ Norberg, T.² Sjogren, S.³ Lindgren, A.⁴ Holberg, L.⁵

26
- 0029155714
- Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer
- (1995) J Natl Cancer Inst , vol.87 , pp. 1254-1256
- Elledge, R.M.¹ Gray, R.² Mansour, E.³ Yu, Y.⁴ Clark, G.M.⁵ Ravdin, P.⁶ Osborne, C.K.⁷ Gilchrist, K.⁸ Davidson, N.E.⁹ Robert, N.¹⁰

27
- 0029063351
- Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAV
- (1995) J Clin Oncol , vol.13 , pp. 1384-1390
- Sarkis, A.S.¹ Bajorin, D.F.² Reuter, V.E.³ Herr, H.W.⁴ Netto, G.⁵ Zhang, Z.F.⁶ Schultz, P.K.⁷ Cordon-Cardo, C.⁸ Scher, H.I.⁹

28
- 0025876591
- The p53 tumour suppressor gene
- (1991) Nature , vol.351 , pp. 453-456
- Levine, A.J.¹ Momand, J.² Finlay, C.A.³

29
- 0027394794
- Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
- (1993) J Natl Cancer Inst , vol.85 , pp. 200-206
- Allred, D.C.¹ Clark, G.M.² Elledge, R.³ Fuqua, S.A.⁴ Brown, R.W.⁵ Chamness, G.C.⁶ Osborne, C.K.⁷ Mc Guire, W.L.⁸

30
- 0033969549
- p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck
- (2000) J Clin Oncol , vol.18 , pp. 385-394
- Temam, S.¹ Flahault, A.² Perie, S.³ Monceaux, G.⁴ Coulet, F.⁵ Callard, P.⁶ Bernaudin, J.F.⁷ St Guilty, J.L.⁸ Fouret, P.⁹

31
- 0027411102
- Nuclear overexpression of p53 in transitional cell bladder carcinoma
- (1993) J Natl Cancer Inst , vol.85 , pp. 53-59
- Sarkis, A.S.¹ Dalbagni, G.² Cordon-Cardo, C.³ Zhang, Z.F.⁴ Sheinfeld, J.⁵ Fair, W.R.⁶ Herr, H.W.⁷ Reuter, V.E.⁸

32
- 0025782858
- Identification of p53 gene mutations in bladder cancer and urine samples
- (1991) Science , vol.252 , pp. 706-709
- Sidransky, D.¹ Von Eschenbach, A.² Tsai, Y.C.³ Jones, P.⁴ Summerhayes, I.⁵ Marshall, F.⁶ Paul, M.⁷ Green, P.⁸ Hamilton, S.R.⁹ Trost, P.¹⁰

33
- 0028051625
- Accumulation of nuclear p53 and tumour progression in bladder cancer
- (1994) N Engl J Med , vol.331 , pp. 1259-1264
- Esrig, D.¹ Elmajian, D.² Groshen, S.³ Freeman, J.A.⁴ Stein, J.P.⁵ Chen, S.C.⁶ Nichols, P.W.⁷ Skinner, D.G.⁸ Jones, P.A.⁹ Cote, R.J.¹⁰

34
- 0034255307
- Tumour mapping of regional immunostaining for p21, p53, and mdm2 in locally advanced bladder carcinoma
- (2000) Cancer , vol.89 , pp. 619-629
- Jahnson, S.¹ Karlsson, M.G.²

35
- 0034108062
- Negative p53/positive p21 immunostaining is a predictor of favorable response to chemotherapy in patients with locally advanced bladder cancer
- (2000) Jpn J Cancer Res , vol.91 , pp. 416-423
- Koga, F.¹ Kithara, S.² Arai, K.³ Honda, M.⁴ Sumi, S.⁵ Yoshida, K.⁶

36
- 0034017584
- Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: A well-tolerated regimen with activity independent of p53 mutation
- (2000) Urology , vol.55 , pp. 521-525
- Edelman, M.J.¹ Meyers, F.J.² Miller, T.R.³ Wlliams, S.G.⁴ Gandour-Edwards, R.⁵ DeVere White, R.W.⁶

37
- 0032713930
- TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle invasive bladder cancer
- (1999) Clin Cancer Res , vol.5 , pp. 3500-3507
- Qureshi, K.N.¹ Griffiths, T.R.² Robinson, M.C.³ Marsh, C.⁴ Roberts, J.T.⁵ Hall, R.R.⁶ Lunec, J.⁷ Neal, D.E.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.